Response to letter to the editor by Mondal H et al. "Delayed breakfast in type 2 diabetes: Critical gaps and translation barriers" [0.03%]
二型糖尿病延迟早餐研究的回信——尚未解决的关键问题及转化障碍
Ana Paula Bravo-Garcia,Evelyn B Parr
Ana Paula Bravo-Garcia
Impact of sodium-glucose co-transporter-2 inhibitor combined with mineralocorticoid receptor antagonist therapy versus either agent alone in individuals with chronic kidney disease: A systematic review and meta-analysis [0.03%]
钠葡萄糖协同转运蛋白-2抑制剂与盐皮质激素受体拮抗剂单用或联用治疗慢性肾脏病的系统评价和.meta.分析
Deep Dutta,A B M Kamrul-Hasan,Sweekruti Jena et al.
Deep Dutta et al.
Background: Sodium-glucose co-transporter-2 inhibitor (SGLT2i) with mineralocorticoid receptor antagonist (MRA) combination therapy (SMCT) hypothetically appears feasible and rational, given their complementary mechanisms...
Low dose pioglitazone (7.5 mg) provides efficacious glycemic control in Asian Indian patients with poorly controlled diabetes compared to 15 mg: A pilot randomized controlled parallel-group open-label trial over 12 months [0.03%]
小剂量吡格列酮（7.5毫克）疗效研究：与15毫克剂量相比，7.5毫克剂量可有效控制印度亚洲糖尿病患者血糖：一项随机对照、开放标签、平行分组试验一年的结果
Rohit Barnabas,Shruti Bhide,Saba Samad Memon et al.
Rohit Barnabas et al.
Aims: We aimed to compare the 1-year efficacy and safety of 7.5 mg versus 15 mg pioglitazone in Asian Indian patients with type 2 diabetes due to lack of long-term data in lower doses. ...
Gliclazide in type 2 diabetes: Cost-effective and clinically relevant in resource-limited settings [0.03%]
二甲双胍在2型糖尿病中的应用：在资源有限的情况下具有成本效益和临床意义
Banshi Saboo,Nitin Kapoor,Balaji Jaganmohan et al.
Banshi Saboo et al.
Burden and trends of diabetic kidney disease in East Asia, 1990-2038: An analysis of the global burden of disease study 2023 [0.03%]
东亚地区1990年至2038年糖尿病肾病的疾病负担及趋势：基于全球疾病负担研究2023的数据分析
Shuai Lin,Ruxin Liu,Guodong Zhong et al.
Shuai Lin et al.
Aim: Diabetic kidney disease is a major cause of chronic and end-stage kidney disease. East Asia, home to one-third of the world's people living with diabetes, is undergoing rapid demographic and metabolic transitions. ...
Experience with insulin detemir for type 2 diabetes in older people and people with comorbidities [0.03%]
二甲双胍治疗老年患者和合并症患者的2型糖尿病的经验
Melanie J Davies,Amra Ciric Alibegovic,Anders Boeck Jensen et al.
Melanie J Davies et al.
Aims: This real-world study assessed glycemic levels and further clinical outcomes, following initiation of detemir, in sub populations of people with T2D vulnerable to hypoglycemia. ...
Differential associations between smoking, e-cigarette use, and diabetes prevalence [0.03%]
吸烟、电子烟使用与糖尿病流行率之间的差异关联性分析
Yusuff Adebayo Adebisi,Chimwemwe Ngoma,Davide Campagna et al.
Yusuff Adebayo Adebisi et al.
Background: Cigarette smoking is a well-established risk factor for diabetes, but the relationship between e-cigarette use and diabetes remains uncertain. Evidence to date has been drawn almost entirely from North America...
Prevalence and risk factors of hypovitaminosis D among patients with diabetes mellitus from India: A systematic review and meta-analysis [0.03%]
印度糖尿病患者维生素D缺乏的患病率和危险因素：系统评价和-meta分析
Gaurab Bhaduri,Shambo Samrat Samajdar,Subhro Chakraborty et al.
Gaurab Bhaduri et al.
Background: There is considerable evidence regarding the potential risk of hypovitaminosis D for various chronic conditions, including type 2 diabetes mellitus (T2DM). Although India essentially shares a tropical climate,...
Artichoke and cardiometabolic health: A systematic and meta-analytic synthesis of current evidence [0.03%]
jerky和心脏代谢健康：现有证据的系统性和元分析综合
Ali Jafari,Mohammad Amin Karimi,Mahsa Mahmoudinezhad et al.
Ali Jafari et al.
Background and aims: This systematic review and meta-analysis was conducted to evaluate the effects of artichoke supplementation on cardiometabolic health markers in adults. ...
From 1990 to 2021, the burden of diabetes among the elderly in the Western Pacific Region (WPR) and projections for 2040 prevalence: A systematic analysis of the 2021 Global Burden of Disease study [0.03%]
糖尿病的疾病负担（1990至2021年）：来自2021年全球疾病负担研究西太平洋地区老年人群估计和2040年预测系统分析
Yve Han,Huaxing Lou,Peng Zhao et al.
Yve Han et al.
Aims: The study aims to quantify the changes in the age-standardized prevalence of Type 1 and type 2 diabetes among the elderly in the Western Pacific Region (WPR) from 1990 to 2021. ...